Waston

Waston Medical Corporation, established in 2002, is one of the most dynamic and innovative suppliers of surgical medical devices and related services in China. The company currently offers five major product categories: orthopedic implants, surgical staplers, thoracic implants, surgical instruments, and medical 3D printers. Orthopedic implants are further divided into trauma fixation, spinal fixation, and artificial joints under development.Located in Wujin High-tech Industrial Development Zone, Jiangsu Province, Waston covers an area of 100,000 square meters with 50,000 square meters of standard factory space, 3,000 square meters of cleanroom, and 3,000 square meters of R&D workshops. More than 40% of the staff are professionals with technical titles in production, R&D, and management. With strong technical support and close cooperation from institutions such as Peking Union Medical College Hospital, General Hospital of Beijing Military Region, Southern Medical University, South China University of Technology, Soochow University, and Changzhou Science and Education City, Waston has developed robust R&D capabilities and manufacturing capacity domestically. The company strictly operates according to ISO and CMD standards, and its products have fully obtained TÜV EU CE certification, with some products being among the first to receive FDA approval. Due to reliable quality and attentive service, Waston's products have gained widespread recognition within the industry in both domestic and international markets.Since obtaining its medical device registration certificate at the end of 2006 and starting market sales, Waston has achieved a doubling of business performance for five consecutive years. In recent years, relying on specialized product structures and technical services, the company has formed mutually beneficial partnerships with distributors. Its orthopedic and thoracic implants, as well as surgical staplers, have entered strong groups within the industry, maintaining an average compound annual growth rate of over 30%.